Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

Clario and AliveCor provide a new trial participant-friendly solution for cutting-edge, at-home data collection with privacy protection, instrumental in situations where traditional 12-lead ECG cannot be collected.
News | ECG
Clario and AliveCor Collaborate to Offer Advanced, Trial- focused Six-lead ECG Solutions for Monitoring in Decentralized Clinical Trials

August 15, 2023 — Clario, a healthcare research technology company that delivers leading endpoint technology solutions ...

Home August 15, 2023
Home
E-cigarettes likely not healthier alternative to traditional cigarettes
News | Stroke
New Evidence Bolsters Theory E-cigarettes May Increase Stroke Risk

August 15, 2023 — There is new evidence that bolsters a possible link between e-cigarette use and increased risk of ...

Home August 15, 2023
Home
Esperion announced two oral presentations to take place in the Late-Breaking Science Session entitled “Clinical trial updates on prevention and lipid lowering” at the 2023 ESC Congress
News | Cardiovascular Clinical Studies
Two CLEAR Outcomes Study Late-Breakers Accepted at European Society of Cardiology (ESC) Congress 2023

August 14, 2023 — Esperion announced two oral presentations to take place in the Late-Breaking Science Session entitled ...

Home August 14, 2023
Home
African Americans have higher average Lp(a) levels and are more likely to have heart disease than non-Hispanic whites, but there is not enough information on Lp(a) and cardiovascular disease risk in this population.
News | Cardiovascular Clinical Studies
Heart Study’s Goal: Better Understand and Serve the Underrepresented

August 10, 2023 — Cardiovascular disease is the number one killer of all Americans. Yet, African Americans are 30% more ...

Home August 10, 2023
Home
Game-changing potential for drug testing and cardiovascular disease treatments - Tiny Heart Model carries massive implications
News | Cardiovascular Clinical Studies
Tiny, Multichambered Human Heart Model Developed by Hebrew University Researchers Could Transform Cardiovascular Research and Drug Evaluation

August 9, 2023 — A team of researchers, led by the Hebrew University of Jerusalem (HU), has developed a tiny human heart ...

Home August 09, 2023
Home
Novo Nordisk A/S: Semaglutide 2.4 mg reduces the risk of major adverse cardiovascular events by 20% in adults with overweight or obesity in the SELECT trial
News | Cardiovascular Clinical Studies
Major Adverse Cardiovascular Events Reduced in Overweight/Obese Patients with Wegovy, per SELECT Trial

August 9, 2023 — Novo Nordisk announced the headline results from the SELECT cardiovascular outcomes trial. The double ...

Home August 09, 2023
Home
Although at greater risk, a new study found that patients of African ancestry with dilated cardiomyopathy (DCM) were less likely to have clinically actionable variants in DCM genes than those of European ancestry.
News | Cardiovascular Clinical Studies
Study Reveals Significant Difference in Cardiomyopathy Genes Between Black and White Patients

August 8, 2023 — Although at greater risk, a new study found that patients of African ancestry with dilated ...

Home August 08, 2023
Home
The medication, known as a “polypill,” includes three active ingredients (acetylsalicylic acid, ramipril, and atorvastatin)
News | Nuclear Imaging
World Health Organization Includes the Cardiovascular Polypill in its list of Essential Medicines after a Groundbreaking Study Led by the President of Mount Sinai Heart

August 3, 2023 — The cardiovascular polypill, developed by the Spanish National Centre for Cardiovascular Research (CNIC ...

Home August 03, 2023
Home
Merit’s WAVE study is a prospective, randomized, controlled, multicenter study
News | Cardiovascular Clinical Studies
Merit Medical’s WRAPSODY Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment

August 3, 2023 — Merit Medical Systems, a leading global manufacturer and marketer of healthcare technology, today ...

Home August 03, 2023
Home
India clinical trial commences with first 30 cases
News | Heart Valve Technology
First Patients Outside of U.S. Treated with TRIA Polymer Surgical Mitral Heart Valve

August 2, 2023 —  Foldax, Inc., a leader in the development of innovative, polymer heart valves, today announced that ...

Home August 02, 2023
Home
LX2020 preclinical studies demonstrated proof-of-concept with treatment restoring desmosomal integrity, reducing arrhythmias, and extending survival in a clinically relevant murine model
News | Pharmaceuticals
LEXEO Therapeutics Announces FDA Clearance of IND for LX2020, an AAV-based Gene Therapy Candidate for PKP2 Arrhythmogenic Cardiomyopathy

August 1, 2023 —LEXEO Therapeutics, a clinical-stage gene therapy company advancing adeno-associated virus (AAV)-based ...

Home August 01, 2023
Home
AI demonstrated high accuracy, reduced non-diagnostic outputs, and identified HFpEF patients with worse outcomes.
News | Cardiovascular Clinical Studies
Study Confirms Ultromics' AI Can Improve HFpEF Detection Using a Single Echocardiogram View

July 31, 2023 — Applying AI to a single apical four chamber (A4C) view echocardiogram provides accurate information to ...

Home July 31, 2023
Home
Primary endpoints across three studies underscore the importance of accuracy, utility, and efficiency in coronary artery disease diagnostics and clinical decision making
News | Cardiovascular Clinical Studies
HeartFlow to Announce New Data at SCCT23

July 28, 2023 — Respective results from the REVEALPLAQUE, DECODE, and SMART-CT clinical studies demonstrate the accuracy ...

Home July 28, 2023
Home
A multi-institutional team of scientists led by Dr. Mario Gaudino, the Stephen and Suzanne Weiss Professor in Cardiothoracic Surgery and assistant dean for clinical trials at Weill Cornell Medicine, has been approved for a nearly $30 million funding award from the Patient-Centered Outcomes Research Institute (PCORI).
News | Cardiovascular Clinical Studies
Large PCORI Award Funds Study of Surgical Options for Coronary Artery Disease in Underrepresented Patient Populations

July 25, 2023 — A multi-institutional team of scientists led by Dr. Mario Gaudino, the Stephen and Suzanne Weiss ...

Home July 25, 2023
Home
BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, announced that the independent Data Safety Monitoring Board (DSMB) has completed its prespecified data review for the ongoing Phase III pivotal CardiAMP Cell Therapy Heart Failure Trial
News | Cardiovascular Clinical Studies
BioCardia Announces DSMB Recommendation to Pause New Enrollment in Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial While Additional Blinded Data is Collected

July 24, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home July 24, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now